Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Calithera’s Kuriakose to head oncology at Terns

Plus: Christine Foster named CBO at hC, and updates from Meliora, Seismic and ClavystBio

March 28, 2023 1:09 AM UTC

Terns Pharmaceuticals Inc. (NASDAQ:TERN) hired Emil Kuriakose as CMO of oncology, effective May 1. Kuriakose joins from Calithera Biosciences Inc. where he was CMO. Current CMO Kerry Russell will become CMO of the metabolic division, where she will lead NASH and obesity programs.

tRNA-based therapies company hC Bioscience Inc. hired Christine Foster as CBO. Foster was CBO at Mnemo Therapeutics S.A.S. and Metagenomi Inc...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article